Cardiac or central nervous system toxicity may result when standard lidocaine doses are administered to patients with circulatory failure. This may be due to the following reason –
**Core Concept**
Standard lidocaine doses can be toxic in patients with circulatory failure due to altered pharmacokinetics and pharmacodynamics. This is related to the drug's dependency on liver metabolism and plasma protein binding for its clearance.
**Why the Correct Answer is Right**
Lidocaine is primarily metabolized by the liver enzyme cytochrome P450 1A2 (CYP1A2). In patients with circulatory failure, liver perfusion is compromised, leading to decreased lidocaine metabolism and increased systemic levels. Furthermore, plasma protein binding of lidocaine is also reduced in these patients, which allows more free lidocaine to bind to its receptor sites, increasing its toxicity.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not address the specific issue of circulatory failure and its impact on lidocaine pharmacokinetics.
**Option B:** This option is incorrect because, while it mentions the role of liver metabolism, it does not explain the impact of reduced liver perfusion in circulatory failure.
**Option C:** This option is incorrect because it does not provide a plausible explanation for the increased toxicity of lidocaine in patients with circulatory failure.
**Clinical Pearl / High-Yield Fact**
In patients with circulatory failure, the use of lidocaine should be carefully monitored, and alternative local anesthetics with different pharmacokinetic profiles should be considered to avoid toxicity.
**Correct Answer: B.**